There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.
Jimmy Xin
Advertisement
Jimmy Xin is scientist at Vector Process Development, ElevateBio.
Articles by Jimmy Xin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Ask the Expert: Commenting on Draft Regulations
2
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
3
Challenges, Innovations, and Future Outlook of Biologics Formulations
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5
